Skip to main content

Day: February 22, 2021

Skattefri fusion af afdelinger i Investeringsforeningen Jyske Invest

Bestyrelsen i Investeringsforeningen Jyske Invest har oprettet fusionsplan og redegørelse for skattefri fusion af følgende afdelinger i Investeringsforeningen Jyske Invest (CVR-nr. 24 26 05 26):Jyske Invest Favorit Obligationer KL (SE-nummer 12258623)fusioneres med Jyske Invest Højt Ratede Virksomhedsobligationer KL (SE-nummer 31006376) som den fortsættende afdelingJyske Invest Danske Aktier KL (SE-nummer 12258763)Jyske Invest Europæiske Aktier KL (SE-nummer 12258852)Jyske Invest Globale Aktier KL (SE-nummer 12258860)Jyske Invest Globale Aktier SRI KL (SE-nummer 31025761)Jyske Invest USA Aktier KL (SE-nummer 12259123)Jyske Invest Favorit Aktier KL (SE-nummer 12259263)fusioneres med Jyske Invest Bæredygtige Aktier KL (SE-nummer 41736607) som den fortsættende afdeling.Fusionen er betinget af, at den vedtages på ordinær generalforsamling i...

Continue reading

Comvest Completes Sale of D&S Community Services to The MENTOR Network

WEST PALM BEACH, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) — Comvest Partners (“Comvest”) is pleased to announce that it has completed the sale of D&S Community Services (“D&S”), a leading provider of residential and community-based services to individuals with intellectual and developmental disabilities (“I/DD”), to The MENTOR Network (“MENTOR”) a premier provider of home and community-based health care and support services.The combined company will offer a comprehensive array of supports and services nationwide to the I/DD population with a fully built-out infrastructure across multiple care settings, enabling delivery of high-quality services to clients and families.Headquartered in Austin, Texas, D&S leverages its quality and compliance management expertise to enhance care and optimize outcomes for individuals with I/DD....

Continue reading

Avid Bioservices Begins Phase 2 of its Myford Manufacturing Capacity Expansion Plan

Build Out of Myford Facility Will Expand Current Footprint to Include Second Manufacturing Train with Both Upstream and Downstream Processing SuitesPhase 2 Has Potential to Increase Annual Revenue Generating Capacity by an Additional $100 MillionTUSTIN, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the initiation of Phase 2 of the company’s two-phase effort to expand the overall manufacturing capacity within its Myford facility. Work is now underway to further build out the company’s Myford facility to include a second manufacturing train with...

Continue reading

Hudbay Announces Offering of US$600 Million Aggregate Principal Amount of Senior Notes

TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE:HBM) today announced that it is offering US$600 million aggregate principal amount of senior notes (the “New Notes”). The interest rate and other terms of the New Notes will be determined at pricing and are dependent upon market conditions and other factors.Hudbay plans to use the net proceeds from the offering of the New Notes to refinance all of its outstanding US$600 million aggregate principal amount of 7.625% senior notes due 2025 (the “Existing Notes”).The redemption of the Existing Notes is conditioned upon the successful closing of the offering of the New Notes, contemporaneous with or prior to the redemption date, and certain other terms and conditions set forth in the company’s redemption notice.The New Notes will not...

Continue reading

urban-gro Strengthens Balance Sheet

– Company eliminates $5.76 million of debt–Well-positioned to access near-term growth opportunities and acquisitions to enhance offering of full turn-key indoor controlled environment agriculture solutionsLAFAYETTE, Colo., Feb. 22, 2021 (GLOBE NEWSWIRE) — urban-gro, Inc. (NASDAQ: UGRO) (“urban-gro” or the “Company”), a leading global horticulture company that engineers and designs commercial Controlled Environment Agriculture (“CEA”) facilities and integrates complex environmental equipment systems into these high-performance facilities, today announced it has extinguished more than 80% of its indebtedness through repayment of $5.76 million in debt. Following this payment, the Company’s total debt is approximately $1.0 million.“urban-gro has made significant progress since the start of 2021. With the completion of our recent financing...

Continue reading

Foghorn Therapeutics to Participate in the 41st Cowen Annual Healthcare Conference

CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) — Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Sam Agresta, M.D., M.P.H, Chief Medical officer is scheduled to participate in a Leukemias panel discussion at the Cowen 41st Annual Healthcare Conference at 11:40 a.m. ET on March 3, 2021.About Foghorn TherapeuticsFoghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory...

Continue reading

Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2021

Catalyst Supporting Facebook Live Panel on Living with a Rare Disease Hosted by The MightyCatalyst Kicks off Rare Reason CampaignCORAL GABLES, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced its support for Rare Disease Day 2021.Rare Disease Day, observed on February 28th this year, involves activities worldwide to raise awareness of rare diseases and their impact on patients’ lives among the general public and decision-makers in industry and government. Efforts taken on this day (and throughout the year) are hoped to increase funds, research, resources, and treatments for the...

Continue reading

First Midwest Bancorp, Inc. Declares Quarterly Dividends

CHICAGO, Feb. 22, 2021 (GLOBE NEWSWIRE) — First Midwest Bancorp, Inc. (the “Company” or “First Midwest”) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share on the Company’s common stock. This quarterly cash dividend will be payable on April 13, 2021 to common stockholders of record on March 26, 2021 and will represent the 153rd consecutive cash dividend paid by First Midwest since its inception in 1983.In addition, the Board of Directors declared a quarterly cash dividend of $17.50 per share (equivalent to $0.4375 per depositary share or 1/40th interest per share) on the Company’s 7.0% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A (NASDAQ: FMBIP) and Series C (NASDAQ: FMBIO). The dividends are payable on May 20, 2021 to stockholders of record as of the close of business...

Continue reading

NV5 Acquires TerraTech Engineers, Strengthening Southeast Geotechnical, Environmental, and Materials Testing Capabilities

HOLLYWOOD, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of compliance, technology, and engineering consulting solutions, announced today that it has acquired TerraTech Engineers, Inc. (“TerraTech”), a geotechnical engineering, environmental consulting, and materials testing company headquartered in North Carolina. TerraTech’s 50 employees serve state and local governments and private clients in North Carolina, South Carolina, and Georgia. NV5 has a proven working relationship with TerraTech and has completed a number of projects with the TerraTech team in the Southeast. TerraTech’s founder and management team will continue with NV5 after the acquisition. The acquisition was made with a combination of cash and stock and will be immediately accretive to NV5’s earnings.  “The...

Continue reading

Xebec Completes Acquisition of Inmatec

MONTREAL, Feb. 22, 2021 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSX: XBC) (“Xebec”), a global provider of clean energy solutions for renewable and low carbon gases, is pleased to announce today the closing of the previously announced acquisition of Inmatec Gase Technologie GmbH & Co. KG, Inmatec GmbH and Inmatec Gas Technology FZC RAK (collectively, “Inmatec”).Inmatec is a leading manufacturer of on-site nitrogen and oxygen generators. With innovative stationary and mobile plants, the company is setting new standards in the on-site production of nitrogen and oxygen. Inmatec’s N2 and O2 product lines with PSA or membrane-based technologies offers solutions to meet the needs of customers of all sizes. In addition, the company provides customer-specific solutions for a range of N2 and O2 applications as part of its special plant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.